Men's knowledge of the human papillomavirus vaccine
Author:
- 1 November 2010
- journal article
- review article
- Published by Wolters Kluwer Health in The Nurse Practitioner
- Vol. 35 (11) , 32-39
Abstract
The FDA recently approved the use of the HPV quadrivalent vaccine, Gardasil, for the prevention of genital warts in males ages 9 through 26. This literature review seeks to examine men's knowledge of and interest in HPV vaccination as this could potentially affect vaccine uptake.Keywords
This publication has 21 references indexed in Scilit:
- Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual menSexually Transmitted Infections, 2009
- Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus InfectionThe Journal of Infectious Diseases, 2009
- Variables Associated With Human Papillomavirus (HPV) Vaccine Acceptance by MenThe Journal of the American Board of Family Medicine, 2009
- Human Papillomavirus Vaccine Acceptability Among Young Adult MenSexually Transmitted Diseases, 2009
- What men who have sex with men think about the human papillomavirus vaccineSexually Transmitted Infections, 2008
- The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: PointCancer Epidemiology, Biomarkers & Prevention, 2008
- Human papillomavirus vaccination in malesGynecologic Oncology, 2007
- Predictors of HPV vaccine acceptability: A theory-informed, systematic reviewPreventive Medicine, 2007
- Model for Assessing Human Papillomavirus Vaccination StrategiesEmerging Infectious Diseases, 2007
- Genital human papillomavirus infection in menThe Lancet Infectious Diseases, 2006